EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update, Annals of the Rheumatic Diseases, vol.69, issue.(Suppl), pp.492-509, 2014. ,
DOI : 10.1136/annrheumdis-2013-204573
Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage, Annals of the Rheumatic Diseases, vol.62, issue.2, pp.120-126, 2003. ,
DOI : 10.1136/ard.62.2.120
The two directions of TNF-related apoptosis-inducing ligand in rheumatoid arthritis, Cytokine, vol.63, issue.2, pp.81-90, 2013. ,
DOI : 10.1016/j.cyto.2013.04.011
Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL???/??? mice, Nature Immunology, vol.4, issue.3, pp.255-60, 2003. ,
DOI : 10.1038/ni894
Tumor Necrosis Factor???Related Apoptosis-Inducing Ligand (Trail) Is an Inhibitor of Autoimmune Inflammation and Cell Cycle Progression, The Journal of Experimental Medicine, vol.155, issue.7, pp.1095-104, 2000. ,
DOI : 10.1016/S1074-7613(00)80400-8
Apo2L/TRAIL and immune regulation, Frontiers in Bioscience, vol.12, issue.1, pp.2074-84, 2007. ,
DOI : 10.2741/2212
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Induces Rheumatoid Arthritis Synovial Fibroblast Proliferation through Mitogen-activated Protein Kinases and Phosphatidylinositol 3-Kinase/Akt, Journal of Biological Chemistry, vol.280, issue.16, pp.15709-15727, 2005. ,
DOI : 10.1074/jbc.M414469200
A New Member of Tumor Necrosis Factor Ligand Family, ODF/OPGL/TRANCE/RANKL, Regulates Osteoclast Differentiation and Function, Biochemical and Biophysical Research Communications, vol.256, issue.3, pp.449-55, 1999. ,
DOI : 10.1006/bbrc.1999.0252
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice, Arthritis & Rheumatism, vol.20, issue.Suppl 1, pp.2042-51, 2003. ,
DOI : 10.1002/art.11150
A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis, Arthritis Research & Therapy, vol.16, issue.3, p.108, 2014. ,
DOI : 10.1038/ng.479
Investigating the Interaction between Osteoprotegerin and Receptor Activator of NF-??B or Tumor Necrosis Factor-related Apoptosis-inducing Ligand: EVIDENCE FOR A PIVOTAL ROLE FOR OSTEOPROTEGERIN IN REGULATING TWO DISTINCT PATHWAYS, Journal of Biological Chemistry, vol.282, issue.43, pp.31601-31610, 2007. ,
DOI : 10.1074/jbc.M706078200
Mechanisms and clinical relevance of TRAIL-triggered responses in the synovial fibroblasts of patients with rheumatoid arthritis, Arthritis & Rheumatism, vol.11, issue.4, pp.904-917, 2011. ,
DOI : 10.1002/art.30181
The ESPOIR cohort: A ten-year follow-up of early arthritis in France, Joint Bone Spine, vol.74, issue.5, pp.440-445, 2007. ,
DOI : 10.1016/j.jbspin.2007.06.001
Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification), J Rheumatol, vol.22, pp.1792-1798, 1995. ,
A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study, Annals of the Rheumatic Diseases, vol.69, issue.7, pp.1333-1340, 2010. ,
DOI : 10.1136/ard.2009.121160
Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort, Arthritis Research & Therapy, vol.15, issue.6, p.210, 2013. ,
DOI : 10.1111/j.1365-2265.2012.04348.x
URL : https://hal.archives-ouvertes.fr/inserm-00926603
First-Year Radiographic Progression as a Predictor of Further Progression in Early Arthritis: Results of a Large National French Cohort, Arthritis Care & Research, vol.6, issue.Suppl 1, pp.1907-1922, 2013. ,
DOI : 10.1002/acr.22078
Comparison of receiver operating characteristic curves on the basis of optimal operating points, Academic Radiology, vol.3, issue.3, pp.245-53, 1996. ,
DOI : 10.1016/S1076-6332(96)80451-X
The Youden index: Letters to the editor, Cancer, vol.3, issue.6, pp.1097-101, 1950. ,
DOI : 10.1002/1097-0142(1950)3:6<1097::AID-CNCR2820030620>3.0.CO;2-E
Osteoprotegerin Exerts Its Pro-inflammatory Effects Through Nuclear Factor-??B Activation, Digestive Diseases and Sciences, vol.40, issue.11, pp.3144-55, 2013. ,
DOI : 10.1007/s10620-013-2851-2
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes, Molecular and Cellular Endocrinology, vol.394, issue.1-2, pp.13-20, 2014. ,
DOI : 10.1016/j.mce.2014.06.004
The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis, Apoptosis, vol.278, issue.6, pp.1623-1655, 2007. ,
DOI : 10.1007/s10495-007-0095-3
Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway, Journal of Cellular Physiology, vol.214, issue.2, pp.536-578, 2008. ,
DOI : 10.1002/jcp.21430
TRAIL Is Involved in Human Osteoclast Apoptosis, Annals of the New York Academy of Sciences, vol.1116, issue.1, pp.316-338, 2007. ,
DOI : 10.1196/annals.1402.011
Tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in human articular chondrocytes in vitro, Biochemical and Biophysical Research Communications, vol.296, issue.3, pp.671-677, 2002. ,
DOI : 10.1016/S0006-291X(02)00916-6
Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study, Arthritis Research & Therapy, vol.10, issue.5, p.106, 2008. ,
DOI : 10.1186/ar2498
URL : https://hal.archives-ouvertes.fr/hal-00375615
A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis, Rheumatology, vol.48, issue.9, pp.1114-1135, 2009. ,
DOI : 10.1093/rheumatology/kep155